Post-COVID Interstitial Lung Disease-The Tip of the Iceberg

Namrata Kewalramani; Kerri-Marie Heenan; Denise McKeegan; Nazia Chaudhuri

doi:10.1016/j.iac.2023.01.004

Post-COVID Interstitial Lung Disease-The Tip of the Iceberg

Namrata Kewalramani
, Kerri-Marie Heenan
, Denise McKeegan
, Nazia Chaudhuri

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

61 Downloads (Pure)

Abstract

The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease. [Abstract copyright: Copyright © 2023 Elsevier Inc. All rights reserved.]

Original language	English
Pages (from-to)	389-410
Number of pages	22
Journal	Immunology and allergy clinics of North America
Volume	43
Issue number	2
Early online date	3 Mar 2023
DOIs	https://doi.org/10.1016/j.iac.2023.01.004
Publication status	Published (in print/issue) - 31 May 2023

Bibliographical note

Funding Information:
N. Kewalramani reports grant and nonfinancial support from CSL Behring, Bern (Switzerland) outside the submitted work. K.-M. Heenan has nothing to disclose. D. McKeegan has nothing to disclose. N. Chaudhuri has nothing to disclose.

Funding

Funding Information: N. Kewalramani reports grant and nonfinancial support from CSL Behring, Bern (Switzerland) outside the submitted work. K.-M. Heenan has nothing to disclose. D. McKeegan has nothing to disclose. N. Chaudhuri has nothing to disclose.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Humans
COVID-19
Post-Acute COVID-19 Syndrome
Respiration Disorders
Lung Diseases, Interstitial - diagnosis - epidemiology - etiology
SARS-CoV-2
Interstitial lung disease
Long-term impact
Post-COVID fibrosis
Post-COVID-19 condition (long COVID)

Access to Document

10.1016/j.iac.2023.01.004

CH0002_Chaudhuri_v3_cleanAuthor Accepted Manuscript, 380 KB

Cite this

@article{b24d44c997944970a9e364eefcf3a2e8,

title = "Post-COVID Interstitial Lung Disease-The Tip of the Iceberg",

abstract = "The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease. [Abstract copyright: Copyright {\textcopyright} 2023 Elsevier Inc. All rights reserved.]",

keywords = "Humans, COVID-19, Post-Acute COVID-19 Syndrome, Respiration Disorders, Lung Diseases, Interstitial - diagnosis - epidemiology - etiology, SARS-CoV-2, Interstitial lung disease, Long-term impact, Post-COVID fibrosis, Post-COVID-19 condition (long COVID)",

author = "Namrata Kewalramani and Kerri-Marie Heenan and Denise McKeegan and Nazia Chaudhuri",

note = "Funding Information: N. Kewalramani reports grant and nonfinancial support from CSL Behring, Bern (Switzerland) outside the submitted work. K.-M. Heenan has nothing to disclose. D. McKeegan has nothing to disclose. N. Chaudhuri has nothing to disclose.",

year = "2023",

month = may,

day = "31",

doi = "10.1016/j.iac.2023.01.004",

language = "English",

volume = "43",

pages = "389--410",

journal = "Immunology and allergy clinics of North America",

issn = "1557-8607",

publisher = "W.B. Saunders Ltd",

number = "2",

}

TY - JOUR

T1 - Post-COVID Interstitial Lung Disease-The Tip of the Iceberg

AU - Kewalramani, Namrata

AU - Heenan, Kerri-Marie

AU - McKeegan, Denise

AU - Chaudhuri, Nazia

N1 - Funding Information: N. Kewalramani reports grant and nonfinancial support from CSL Behring, Bern (Switzerland) outside the submitted work. K.-M. Heenan has nothing to disclose. D. McKeegan has nothing to disclose. N. Chaudhuri has nothing to disclose.

PY - 2023/5/31

Y1 - 2023/5/31

N2 - The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease. [Abstract copyright: Copyright © 2023 Elsevier Inc. All rights reserved.]

AB - The proportion of symptomatic patients with post-coronavirus 2019 (COVID-19) condition (long COVID) represents a significant burden on the individual as well as on the health care systems. A greater understanding of the natural evolution of symptoms over a longer period and the impacts of interventions will improve our understanding of the long-term impacts of the COVID-19 disease. This review will discuss the emerging evidence for the development of post-COVID interstitial lung disease focusing on the pathophysiological mechanisms, incidence, diagnosis, and impact of this potentially new and emerging respiratory disease. [Abstract copyright: Copyright © 2023 Elsevier Inc. All rights reserved.]

KW - Humans

KW - COVID-19

KW - Post-Acute COVID-19 Syndrome

KW - Respiration Disorders

KW - Lung Diseases, Interstitial - diagnosis - epidemiology - etiology

KW - SARS-CoV-2

KW - Interstitial lung disease

KW - Long-term impact

KW - Post-COVID fibrosis

KW - Post-COVID-19 condition (long COVID)

UR - https://www.scopus.com/pages/publications/85149644086

U2 - 10.1016/j.iac.2023.01.004

DO - 10.1016/j.iac.2023.01.004

M3 - Article

C2 - 37055095

SN - 1557-8607

VL - 43

SP - 389

EP - 410

JO - Immunology and allergy clinics of North America

JF - Immunology and allergy clinics of North America

IS - 2

ER -

Post-COVID Interstitial Lung Disease-The Tip of the Iceberg

Abstract

Bibliographical note

Funding

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this